Early-stage IVD firm Jana Care and testing market behemoth Roche Diagnostics on Monday announced a collaboration agreement to develop and distribute a digitally connected, blood-testing platform for chronic kidney and heart disease.
The platform would enable patients to self-administer critical blood tests at home, and clinicians would review the test results remotely.
Financial and other terms of the agreement were not disclosed.
"The need for improving real point-of-care testing is critical as innovation needs to keep pace with our more decentralized healthcare model," Anh Hoang-Lindsay, CEO of Watertown, MA-based Jana Care, said in a statement.
The platform is designed to overcome distance and socioeconomic hurdles impeding adequate and timely detection and monitoring of disease progression and risk management, Jana Care said, adding that the initial focus of the collaboration will be on monitoring the progression of chronic kidney disease and heart failure.
Health-related quality of life is substantially lower for the 37 million and 6.5 million people living with chronic kidney disease and congestive heart failure respectively in the U.S. Regular testing is critically important to monitor disease progression and quickly respond, and blood tests to monitor these patients in at-home settings are generally not available, Jana Care noted.